BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31274159)

  • 1. CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
    Colafrancesco S; Priori R; Smith CG; Minniti A; Iannizzotto V; Pipi E; Lucchesi D; Pontarini E; Nayar S; Campos J; Arienzo F; Fusconi M; Cerbelli B; Giordano C; Valesini G; Bombardieri M; Fisher BA; Barone F
    Rheumatology (Oxford); 2020 Jan; 59(1):165-170. PubMed ID: 31274159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
    Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
    Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Barone F; Bombardieri M; Manzo A; Blades MC; Morgan PR; Challacombe SJ; Valesini G; Pitzalis C
    Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
    Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
    Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
    Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
    Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
    Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
    Szodoray P; Alex P; Jonsson MV; Knowlton N; Dozmorov I; Nakken B; Delaleu N; Jonsson R; Centola M
    Clin Immunol; 2005 Nov; 117(2):168-76. PubMed ID: 16126006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
    Salomonsson S; Jonsson MV; Skarstein K; Brokstad KA; Hjelmström P; Wahren-Herlenius M; Jonsson R
    Arthritis Rheum; 2003 Nov; 48(11):3187-201. PubMed ID: 14613282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
    Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
    Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
    Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren's syndrome.
    Leehan KM; Pezant NP; Rasmussen A; Grundahl K; Moore JS; Radfar L; Lewis DM; Stone DU; Lessard CJ; Rhodus NL; Segal BM; Kaufman CE; Scofield RH; Sivils KL; Montgomery C; Farris AD
    Autoimmunity; 2017 Dec; 50(8):451-457. PubMed ID: 28988489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
    Zhu T; Pan Z; Zhang N
    Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor salivary gland fibrosis in Sjögren's syndrome is elevated, associated with focus score and not solely a consequence of aging.
    Leehan KM; Pezant NP; Rasmussen A; Grundahl K; Moore JS; Radfar L; Lewis DM; Stone DU; Lessard CJ; Rhodus NL; Segal BM; Scofield RH; Sivils KL; Montgomery C; Farris AD
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):80-88. PubMed ID: 29148407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association between salivary gland disease and serological abnormalities in Sjögren's syndrome.
    Nakamura S; Ikebe-Hiroki A; Shinohara M; Ohyama Y; Mouri T; Sasaki M; Shirasuna K; Nomoto K
    J Oral Pathol Med; 1997 Oct; 26(9):426-30. PubMed ID: 9385581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
    Carubbi F; Alunno A; Cipriani P; Di Benedetto P; Ruscitti P; Berardicurti O; Bartoloni E; Bistoni O; Caterbi S; Ciccia F; Triolo G; Gerli R; Giacomelli R
    Semin Arthritis Rheum; 2014 Dec; 44(3):314-24. PubMed ID: 24935529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.